 |  |  |  |  |
| | | | |
Through the assistance of our many supporters we have the power to take on new projects and be successful.
We work together with accredited partners from the fields of Research and Therapy. We find it important to work with established professionals and scientist that are committed to our cause. They have to be willing to take on considerable responsibility when it comes to our projects.
At the moment all of our Medical Advisors are volunteering their time, however once we progress to the next level, they will have to be compensated. This is one of the reasons that we are in need of financial support. With enough financing we would be able to start new projects
We are a young company, which has a unique partnership with the orphanbiotec foundation. We work towards the development and implementation of new medications for Rare Diseases.
The company supervises the development of medications until they are put on the market and available to patients. We initiate the creative effort and manage the individual projects until their final stage.
We are 4 founders, 2 of whom, Dr. Frank Grossmann and Marcel Knoerle lead the operational aspect of the business. We use accumulated knowledge of plant substances to develop Orphan Drugs in cooperation with researchers and partner companies.
The orphanbiotec foundation ensures that financing meant for projects is safeguarded. We make sure that new products are approved and they fall in the hands of doctors and specialists who can use them to help patients.